The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury
Sponsor: James J. Peters Veterans Affairs Medical Center
Terminated
Study ended early due to COVID-19
Other terminated trials from James J. Peters Veterans Affairs Medical Center
See all terminations from James J. Peters Veterans Affairs Medical Center
This PHASE4 trial investigates Secondary Osteoporosis and Spinal Cord Injury and is currently terminated or withdrawn. James J. Peters Veterans Affairs Medical Center leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jan 2024 — Apr 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2021 — Jan 2024 [monthly]
Recruiting PHASE4
-
Apr 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2017 — Mar 2018 [monthly]
Not Yet Recruiting PHASE4
Phase: PHASE2 → PHASE4
-
Feb 2017 — Mar 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- James J. Peters Veterans Affairs Medical Center
- Kessler Institute for Rehabilitation
For direct contact, visit the study record on ClinicalTrials.gov .